|
Cost-effectiveness analysis of apixaban compared to dabigatran in the prevention of venous thromboembolism in patients subjected to total knee or hip replacement |
Gomez-Cerezo JF, Gomez-Arrayas I, Suarez-Fernandez C, Betegon-Nicolas L, de Salas-Cansado M, Rubio-Terres C |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Gomez-Cerezo JF, Gomez-Arrayas I, Suarez-Fernandez C, Betegon-Nicolas L, de Salas-Cansado M, Rubio-Terres C. Cost-effectiveness analysis of apixaban compared to dabigatran in the prevention of venous thromboembolism in patients subjected to total knee or hip replacement. Revista Espanola de Cirugia Ortopedica y Traumatologia 2012 Nov-Dec; 56(6): 459-470 Indexing Status Subject indexing assigned by NLM MeSH Anticoagulants /economics /therapeutic use; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles /economics /therapeutic use; Cost-Benefit Analysis; Dabigatran; Hospital Costs /statistics & Humans; Markov Chains; Models, Economic; Postoperative Complications /economics /mortality /prevention & Pulmonary Embolism /economics /etiology /mortality /prevention & Pyrazoles /economics /therapeutic use; Pyridones /economics /therapeutic use; Spain; Treatment Outcome; Venous Thromboembolism /economics /etiology /mortality /prevention & Venous Thrombosis /economics /etiology /mortality /prevention & beta-Alanine /analogs & control; control; control; control; derivatives /economics /therapeutic use; numerical data AccessionNumber 22013016500 Date bibliographic record published 10/05/2013 |
|
|
|